{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:14:31Z","timestamp":1783329271883,"version":"3.54.6"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omton.2026.201207","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T14:59:05Z","timestamp":1776524345000},"page":"201207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fibulin-4 expressed in metastatic breast cancer is a target of peptide-based imaging probes and experimental therapeutics"],"prefix":"10.1016","volume":"34","author":[{"given":"Alexes C.","family":"Daquinag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhen C.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solmaz","family":"AghaAmiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Servando Hernandez","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin K.","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Azhdarinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3743-7869","authenticated-orcid":false,"given":"Mikhail G.","family":"Kolonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201207_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","article-title":"Targeting metastatic cancer","volume":"27","author":"Ganesh","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201207_bib2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s43018-021-00181-0","article-title":"Emerging strategies for treating metastasis","volume":"2","author":"Esposito","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.omton.2026.201207_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.46439\/signaling.1.020","article-title":"Probes for cancer metastasis imaging and therapeutic targeting","volume":"1","author":"Adhikari","year":"2023","journal-title":"Cell Signaling"},{"key":"10.1016\/j.omton.2026.201207_bib4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm1469","article-title":"Tumor metastasis: mechanistic insights and clinical challenges","volume":"12","author":"Steeg","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201207_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrc3180","article-title":"Treating metastatic cancer with nanotechnology","volume":"12","author":"Schroeder","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omton.2026.201207_bib6","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1158\/0008-5472.CAN-21-1015","article-title":"Characterization of peptides targeting metastatic tumor cells as probes for cancer detection and vehicles for therapy delivery","volume":"81","author":"Subramanian","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2026.201207_bib7","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1002\/cncr.29344","article-title":"Targeting the interleukin-11 receptor alpha in metastatic prostate cancer: A first-in-man study","volume":"121","author":"Pasqualini","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.omton.2026.201207_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1541-7786.MCR-19-0582","article-title":"Antibody-Drug Conjugates: A Comprehensive Review","volume":"18","author":"Khongorzul","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.omton.2026.201207_bib9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.matbio.2014.02.004","article-title":"Fibulin-4 and fibulin-5 in elastogenesis and beyond: Insights from mouse and human studies","volume":"37","author":"Papke","year":"2014","journal-title":"Matrix Biol."},{"key":"10.1016\/j.omton.2026.201207_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12885-015-1100-9","article-title":"Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas","volume":"15","author":"Chen","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omton.2026.201207_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10549-018-4781-3","article-title":"Correction to: Secretomes reveal several novel proteins as well as TGF-beta1 as the top upstream regulator of metastatic process in breast cancer","volume":"170","author":"Erin","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.omton.2026.201207_bib12","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.25.12.126002","article-title":"Development of a drug-device combination for fluorescence-guided surgery in neuroendocrine tumors","volume":"25","author":"Hernandez Vargas","year":"2020","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.omton.2026.201207_bib13","article-title":"A proof-of-concept methodology to validate the in situ visualization of residual disease using cancer-targeted molecular agents in fluorescence-guided surgery","volume":"11222","author":"Vargas","year":"2020","journal-title":"Proc. SPIE. Int. Soc. Opt. Eng."},{"key":"10.1016\/j.omton.2026.201207_bib14","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1021\/acsmedchemlett.7b00125","article-title":"Synthesis of a Fluorescently Labeled (68)Ga-DOTA-TOC Analog for Somatostatin Receptor Targeting","volume":"8","author":"Ghosh","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.omton.2026.201207_bib15","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.2967\/jnumed.116.187971","article-title":"A Modular Dual-Labeling Scaffold That Retains Agonistic Properties for Somatostatin Receptor Targeting","volume":"58","author":"Ghosh","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.omton.2026.201207_bib16","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1158\/1078-0432.CCR-18-3312","article-title":"Specific Targeting of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery","volume":"25","author":"Hernandez Vargas","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201207_bib17","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1038\/s41467-021-23793-7","article-title":"Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance","volume":"12","author":"Yamazaki","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201207_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/1536012118801223","article-title":"Application of Immuno-PET in Antibody-Drug Conjugate Development","volume":"17","author":"Carmon","year":"2018","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.omton.2026.201207_bib19","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/1535-7163.MCT-16-0114","article-title":"LGR5-Targeted Antibody-Drug Conjugate Eradicates Gastrointestinal Tumors and Prevents Recurrence","volume":"15","author":"Gong","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omton.2026.201207_bib20","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1158\/1535-7163.MCT-19-0022","article-title":"Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer","volume":"18","author":"Whalen","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omton.2026.201207_bib21","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/acs.bioconjchem.3c00147","article-title":"Development of Antiplasmodial Peptide-Drug Conjugates Using a Human Protein-Derived Cell-Penetrating Peptide with Selectivity for Infected Cells","volume":"34","author":"Palombi","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omton.2026.201207_bib22","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1038\/ncomms3472","article-title":"A peptide probe for targeted brown adipose tissue imaging","volume":"4","author":"Azhdarinia","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201207_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/mt.2015.155","article-title":"Targeted Pro-apoptotic Peptides Depleting Adipose Stromal Cells Inhibit Tumor Growth","volume":"24","author":"Daquinag","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201207_bib24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/cdd.2014.148","article-title":"Depletion of white adipocyte progenitors induces beige adipocyte differentiation and suppresses obesity development","volume":"22","author":"Daquinag","year":"2015","journal-title":"Cell Death & Diff"},{"key":"10.1016\/j.omton.2026.201207_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102131","article-title":"Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy","volume":"14","author":"Cho","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omton.2026.201207_bib26","doi-asserted-by":"crossref","first-page":"20428","DOI":"10.1073\/pnas.1901048116","article-title":"Fibulin-4 exerts a dual role in LTBP-4L-mediated matrix assembly and function","volume":"116","author":"Kumra","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2026.201207_bib27","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nm1048","article-title":"Reversal of obesity by targeted ablation of adipose tissue","volume":"10","author":"Kolonin","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201207_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.omto.2020.08.012","article-title":"Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis","volume":"18","author":"Su","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omton.2026.201207_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/2767-9764.CRC-24-0298","article-title":"Depletion of Adipose Stroma-Like Cancer-Associated Fibroblasts Potentiates Pancreatic Cancer Immunotherapy","volume":"5","author":"Rupert","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.omton.2026.201207_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13045-025-01704-3","article-title":"Antibody-Drug Conjugates (ADCs): current and future biopharmaceuticals","volume":"18","author":"Wang","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.omton.2026.201207_bib31","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJMoa2511734","article-title":"Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer","volume":"393","author":"Cort\u00e9s","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2026.201207_bib32","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1158\/1535-7163.MCT-24-0254","article-title":"177Lu-Labeled Antibody-Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors","volume":"24","author":"Yamaguchi","year":"2025","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omton.2026.201207_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/genes12060795","article-title":"LTBP4 in Health and Disease","volume":"12","author":"Su","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.omton.2026.201207_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc1404","article-title":"A matricellular protein fibulin-4 is essential for the activation of lysyl oxidase","volume":"6","author":"Noda","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omton.2026.201207_bib35","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202402767R","article-title":"Fibulin-4 and latent-transforming growth factor beta-binding protein-4 interactions with syndecan-2 and syndecan-3 are required for elastogenesis","volume":"39","author":"Hakami","year":"2025","journal-title":"FASEB J."},{"key":"10.1016\/j.omton.2026.201207_bib36","doi-asserted-by":"crossref","first-page":"22821","DOI":"10.1074\/jbc.M112.439158","article-title":"Fibulin-3, -4, and -5 are highly susceptible to proteolysis, interact with cells and heparin, and form multimers","volume":"288","author":"Djokic","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2026.201207_bib37","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3892\/ijo.2017.3921","article-title":"Fibulin-4 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition via the PI3K\/Akt\/mTOR pathway","volume":"50","author":"Zhang","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.omton.2026.201207_bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10549-018-4752-8","article-title":"Secretomes reveal several novel proteins as well as TGF-beta1 as the top upstream regulator of metastatic process in breast cancer","volume":"170","author":"Erin","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.omton.2026.201207_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114377","article-title":"Antibody-activation of connexin hemichannels in bone osteocytes with ATP release suppresses breast cancer and osteosarcoma malignancy","volume":"43","author":"Riquelme","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2026.201207_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omto.2017.05.003","article-title":"Non-glycanated Decorin is a Drug Target on Human Adipose Stromal Cells","volume":"6","author":"Daquinag","year":"2017","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omton.2026.201207_bib41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.omton.2026.201207_bib42","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omton.2026.201207_bib43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein-protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omton.2026.201207_bib44","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/0008-5472.CAN-12-0294","article-title":"Stromal progenitor cells from endogenous adipose tissue contribute to pericytes and adipocytes that populate the tumor microenvironment","volume":"72","author":"Zhang","year":"2012","journal-title":"Cancer Res."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:17:29Z","timestamp":1783325849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926000834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2950329926000834"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201207","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibulin-4 expressed in metastatic breast cancer is a target of peptide-based imaging probes and experimental therapeutics","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201207"}}